Driver mutation impact in Chinese hepatocellular carcinoma
Ruiheng Wu, Houmin Xing, Jeffrey P Townsend · 2026
Read Driver mutation impact in Chinese hepatocellular carcinoma by Ruiheng Wu, Houmin Xing, Jeffrey P Townsend (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0355717.txt.
Description
Ruiheng Wu, Houmin Xing, and Jeffrey P Townsend re-analyzed whole genomes from 494 Chinese liver tumors, asking not just which mutations recur but which ones actually give cancer cells an edge. Their 2026 study computed, for every recurrent mutation, a scaled measure of the selective advantage it confers, using each gene's background mutation rate as the neutral yardstick.
The usual giants, including CTNNB1, TP53, and a famous regulatory hotspot, showed intense positive selection. More interestingly, several rare candidates, including genes tied to collagen chemistry and immune signaling, carried outsized effects, while some previously nominated drivers looked no better than neutral passengers. The authors stress the rare finds are computational priorities for laboratory proof, not established drivers.
Catalog record
| CREATOR | Ruiheng Wu, Houmin Xing, Jeffrey P Townsend |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42403 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |